Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

ELAC2 polymorphisms and prostate cancer risk: a meta-analysis based on 18 case-control studies.

Prostate cancer and prostatic diseases - 1 Sept 2010

Xu B, Tong N, Li J-m, Zhang Z-d, Wu H-f

Abstract excerpt

Polymorphisms in the elaC homolog-2 (ELAC2)/HPC2 gene have been hypothesized to alter the risk of prostate cancer. However, the results of the related published studies remained conflicting. We performed a meta-analysis of 18 studies evaluating the association between ELAC2 Ser217Leu and Ala541Thr polymorphisms and prostate cancer risk. Overall, ELAC2 Leu217 allele was associated with increased prostate cancer...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Case-Control Studies
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasm Proteins

Share to Polymorphism, Single Nucleotide

Share to Prostatic Neoplasms

Share to Risk Factors

Source

Open in PubMed Open full text

Identifiers

PMID: 20231859
DOI: 10.1038/pcan.2010.6
PMCID: PMC2922791

Genes

ELAC2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

ELAC2 polymorphisms and prostate cancer risk: a meta-analysis based on 18 case-control studies.PMID 20231859Read ↗

Association of common missense changes in ELAC2 ( HPC2) with prostate cancer in a Japanese case-control series.Semantic proximity Read ↗

ELAC2/HPC2 polymorphisms, prostate-specific antigen levels, and prostate cancer.Semantic proximity Read ↗

Association of HPC2/ELAC2 polymorphism with prostate cancer risk in a Japanese population.Semantic proximity Read ↗

Meta-analysis of associations of the Ser217Leu and Ala541Thr variants in ELAC2 (HPC2) and prostate cancer.Semantic proximity Read ↗

Association of HPC2/ELAC2 polymorphisms with risk of prostate cancer in a population-based study.Semantic proximity Read ↗

HPC2/ELAC2 polymorphism associated with Japanese sporadic prostate cancer.Semantic proximity Read ↗

Association of HPC2/ELAC2 genotypes and prostate cancer.Semantic proximity Read ↗

Evaluation of linkage and association of HPC2/ELAC2 in patients with familial or sporadic prostate cancer.Semantic proximity Read ↗

Ser217Leu polymorphism of the HPC2/ELAC2 gene associated with prostatic cancer risk in Japanese men.Semantic proximity Read ↗

HPC2/ELAC2 gene variants associated with incident prostate cancer.Semantic proximity Read ↗

Genetic analysis of the principal genes related to prostate cancer: a review.Semantic proximity Read ↗

Prostate cancer susceptibility genes: many studies, many results, no answers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.